Subsequently, we evaluated the efficacy of sequential administration of anti-PD-1 and anti-Tim-3 antibodies combined with the Anchored GM-CSF vaccine in long-established PCa mouse models. This evidence concerns the gene HAVCR2 and posterior cortical atrophy.